Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025)

Amarin Corp Plc\Uk (AMRN) posted quarterly Other Accumulated Expenses of $18.3 million for Q4 2025, up 4.52% year-over-year from $17.5 million in Q4 2024, and up 4.52% quarter-over-quarter from $17.5 million in Q4 2024.

Amarin Corp Plcuk (AMRN) Other Accumulated Expenses (2010 - 2025) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Other Accumulated Expenses for 16 consecutive years, with $18.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Accumulated Expenses rose 4.52% year-over-year to $18.3 million; the TTM figure through Dec 2025 stood at $18.3 million (up 4.52% YoY), while the FY2025 annual figure was $18.3 million, up 4.52% from the prior year.
  • Other Accumulated Expenses improved to $18.3 million in Q4 2025 per AMRN's latest filing, from $17.5 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $45.6 million in Q4 2021 and bottomed at $17.5 million in Q4 2024.
  • Historically, Other Accumulated Expenses has averaged $28.0 million across 5 years, with a median of $23.0 million in 2023.
  • Annual changes were most pronounced in 2021 — Other Accumulated Expenses surged 58.42% — and 2023, when it sank 35.41%.
  • Amarin Corp Plc\Uk's Other Accumulated Expenses stood at $45.6 million in 2021, then retreated by 21.84% to $35.6 million in 2022, then tumbled by 35.41% to $23.0 million in 2023, then slipped by 23.79% to $17.5 million in 2024, then climbed by 4.52% to $18.3 million in 2025.
  • Business Quant data shows AMRN's Other Accumulated Expenses at $18.3 million in Q4 2025, $17.5 million in Q4 2024, and $23.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 18.34 Mn
Dec 31, 2024 17.55 Mn
Dec 31, 2023 23.02 Mn
Dec 31, 2022 35.64 Mn
Dec 31, 2021 45.60 Mn
Dec 31, 2020 28.79 Mn
Dec 31, 2019 16.59 Mn
Dec 31, 2018 7.71 Mn
Dec 31, 2017 5.16 Mn
Dec 31, 2016 5.80 Mn
Dec 31, 2015 4.28 Mn
Dec 31, 2014 2.25 Mn
Dec 31, 2013 3.34 Mn
Dec 31, 2012 3.15 Mn
Dec 31, 2011 1.78 Mn
Dec 31, 2010 572,000.00